Vol. 151, No. 7 — April 5, 2017

Registration

SOR/2017-44 March 24, 2017

CONTROLLED DRUGS AND SUBSTANCES ACT

Order Amending Schedule III to the Controlled Drugs and Substances Act (Methylphenidate)

P.C. 2017-255 March 24, 2017

His Excellency the Governor General in Council, on the recommendation of the Minister of Health, pursuant to section 60 of the Controlled Drugs and Substances Act (see footnote a), deeming that it is necessary in the public interest, makes the annexed Order Amending Schedule III to the Controlled Drugs and Substances Act (Methylphenidate).

Order Amending Schedule III to the Controlled Drugs and Substances Act (Methylphenidate)

Amendment

1 Item 2 of Schedule III to the Controlled Drugs and Substances Act (see footnote 1) is replaced by the following:

• 2 Methylphenidate (methyl 2-phenyl-2-(piperidin-2-yl)acetate), its salts, derivatives, isomers and analogues and salts of derivatives, isomers and analogues, including
  • (1) Ethylphenidate (ethyl 2-phenyl-2-(piperidin-2-yl)acetate)
  • (2) Isopropylphenidate (isopropyl 2-phenyl-2-(piperidin-2-yl)acetate)
  • (3) Propylphenidate (propyl 2-phenyl-2-(piperidin-2-yl)acetate)
  • (4) 3,4-Dichloromethylphenidate (methyl 2-(3,4-dichlorophenyl)-2-(piperidin2-yl)acetate)
  • (5) 4-Methylmethylphenidate (methyl 2-(4-methylphenyl)-2-(piperidin2-yl)acetate)
  • (6) 4-Fluoromethylphenidate (methyl 2-(4-fluorophenyl)-2-(piperidin-2-yl)acetate)
  • (7) Methylnaphthidate (methyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)
  • (8) Ethylnaphthidate (ethyl 2-(naphthalen-2-yl)-2-(piperidin-2-yl)acetate)

Coming into Force

2 This Order comes into force on the 30th day after the day on which it is published in the Canada Gazette, Part II.

N.B. The Regulatory Impact Analysis Statement for this Order appears following SOR/2017-43, Regulations Amending the Food and Drug Regulations (Part G — Methylphenidate).

• Footnote a
  S.C. 1996, c. 19
• Footnote 1
  S.C. 1996, c. 19